BioCatalystWatch
KALVWorkspace / KALV / OverviewCompany library
KalVista Pharmaceuticals, Inc. logo

KalVista Pharmaceuticals, Inc.

KalVista Pharmaceuticals, Inc. (KALV)

Website

Featured programme · EKTERLY® (sebetralstat)

Price
Market cap
Next catalyst—
Cash

Chart & Events

Candle interval

Core Clinical

EKTERLY® (sebetralstat)

Small molecule

Plasma kallikrein

PreINDP1P2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

EKTERLY® (sebetralstat)

Small molecule

Plasma kallikrein

PreINDP1P2P3FilingApproved
Upcoming / outlook

Other pipelines

Approved / commercial

EKTERLY® (sebetralstat)

Small molecule

Plasma kallikrein

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

History / paused

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing





PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

KALV PR & News

PR & News

KALV SEC archive